Tumor Microenvironment (TME) Chip Customization Service Powered CAR-T Development

Online Inquiry

Background Service What we can offer Workflow HighlightsFAQs Contact

Solid tumors remain a major barrier for CAR-T therapies due to immunosuppressive signaling, limited T-cell infiltration, and misleading efficacy results from conventional 2D assays. Our TME Chip Customization Service enables physiologically relevant evaluation of CAR-T performance by integrating microfluidic architecture, 3D bioprinted tumor stromal compartments, and immune vascular interfaces within a controllable, human-relevant platform. Combined with real-time biosensing and dynamic perfusion, these customized TME chips recapitulate key features of solid tumor biology, allowing precise assessment of CAR-T infiltration, persistence, cytotoxicity, and safety.

Introduction

Advanced in vitro tumor models increasingly demonstrate that reproducing immune tumor stroma interactions improves the predictability of immunotherapy outcomes. Microengineered TME systems enable dynamic gradients, multicellular crosstalk, and real-time observation, supporting more reliable assessment of CAR-T behavior in solid tumor-like settings. These approaches complement existing models by providing mechanistic insights and faster iteration during preclinical development.

Fig.1 Microfluidic chips allow for the adoption of a more holistic approach in modeling the complex TME. (OA Literature) Fig.1 Microfluidic chips enable a more holistic approach to modeling the complex tumor microenvironment (TME).¹

Service

Creative Biolabs bridges the gap between early-stage CAR-T design and clinical reality. By simulating the physical and chemical hurdles of the TME, such as interstitial fluid pressure, hypoxia, and dense extracellular matrices, we deliver actionable data on CAR-T persistence, metabolic fitness, and tumor-killing efficiency.

Physiologically relevant efficacy assessment: Quantify CAR-T infiltration, cytotoxicity, persistence, and exhaustion under controlled TME conditions.
Mechanism-focused optimization: Dissect immune suppression, stromal barriers, and hypoxia impacts to guide CAR design and combination strategies.
Comparative screening: Benchmark constructs, dosing, and schedules within the same standardized microenvironment.
Translational alignment: Generate data that bridges simple in vitro assays and in vivo studies.

Discover How We Can Help - Request a Consultation to design a chip model that meets your specific research needs.

What We Can Offer

Flexible platforms tailored to CAR-T research needs.

Microfluidic TME chips: Multi-compartment designs enabling immune trafficking, stromal barriers, and nutrient/oxygen gradients.
3D tumor constructs: Matrix-supported tumor assemblies incorporating stromal and immune components.
Vascularized interfaces: Endothelial layers to assess extravasation and infiltration dynamics.
Modular immunosuppression elements: Tunable cytokine, checkpoint-ligand, and metabolic stress features.
Imaging and analytics integration: Real-time visualization and quantitative readouts aligned to CAR-T endpoints.

Our Workflow

Required Starting Materials:

CAR-T cell specifications (target antigen, construct features, dosing plan).

Tumor context details (tumor type, cellular composition, matrix preferences).

Study objectives (efficacy comparison, infiltration analysis, mechanism probing).

Workflow of TME Chip Customization. (Creative Biolabs Original)

Final Deliverables:

Comprehensive study report with quantitative metrics and visualizations.

Raw and processed datasets suitable for downstream analysis.

Practical recommendations for construct optimization or next-step studies.

Benefits

Higher Translational Relevance: Recreates key tumor microenvironment barriers that conventional 2D or simple 3D models cannot capture.
Mechanism-Driven Insights: Enables direct observation of CAR-T infiltration, persistence, and functional suppression under defined TME conditions.
Customizable & Modular: Flexible integration of stromal, immune, and biochemical factors tailored to specific tumor indications.
Reduced Development Risk: Identifies failure modes earlier, supporting informed construct optimization and study prioritization.

FAQs

Q1: How do customized TME chips compare to traditional mouse models for CAR-T testing?

A: While mouse models provide systemic context, they often lack human-specific immune ligands and fail to replicate human stromal stiffness. Our TME chips use human cells and offer spatiotemporal control, allowing you to visualize T-cell behavior at a resolution impossible in vivo.

Q2: Can you simulate the specific pH and oxygen levels found in my target tumor type?

A: Yes. Our chips feature integrated microfluidic gas controllers and ratiometric sensors that allow us to maintain and monitor precise levels of hypoxia and extracellular acidification tailored to your specific disease model.

Q3: What is the benefit of integrating 3D bioprinting into the chip?

A: 3D bioprinting allows us to place CAFs, endothelial cells, and tumor cells in precise spatial arrangements. This creates a realistic diffusion gradient for nutrients and drugs, which is critical for assessing CAR-T penetration.

Partner with Us

Creative Biolabs provides the industry's most advanced TME Chip Customization Service, specifically engineered to solve the unique challenges of CAR-T development in solid tumors. By integrating sophisticated microfluidics, bioprinting, and real-time analytical tools, we empower your research with predictive, human-relevant data that accelerates the path to clinical success. Contact Our Team for More Information and to Discuss Your Project. Ready to overcome the TME barrier? Our specialists are available to design a customized platform for your unique CAR-T program.

Reference

Gaebler, Daniela et al. "Improving tumor microenvironment assessment in chip systems through next-generation technology integration." Frontiers in bioengineering and biotechnology vol. 12 1462293. 25 Sep. 2024. Distributed under Open Access License CC BY 4.0, without modification. https://doi.org/10.3389/fbioe.2024.1462293

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.